Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
1 "Arrhythmias, cardiac"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Review
Obesity and Metabolic Syndrome
Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases
Eugene Han, Yong-ho Lee
Diabetes Metab J. 2017;41(6):430-437.   Published online November 17, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.6.430
  • 5,922 View
  • 92 Download
  • 53 Web of Science
  • 58 Crossref
AbstractAbstract PDFPubReader   

As the number of individuals with non-alcoholic fatty liver disease (NAFLD) has increased, the influence of NAFLD on other metabolic diseases has been highlighted. Accumulating epidemiologic evidence indicates that NAFLD not only affects the liver but also increases the risk of extra-hepatic diseases such as type 2 diabetes mellitus, metabolic syndrome, dyslipidemia, hypertension, cardiovascular or cerebrovascular diseases, and chronic kidney disease. Non-alcoholic steatohepatitis, an advanced type of NAFLD, can aggravate these inter-organ relationships and lead to poorer outcomes. NAFLD induces insulin resistance and exacerbates systemic chronic inflammation and oxidative stress, which leads to organ dysfunction in extra-hepatic tissues. Although more research is needed to identify the pathophysiological mechanisms and causal relationship between NAFLD and cardiometabolic and renal diseases, screening for heart, brain, and kidney diseases, risk assessment for diabetes, and a multidisciplinary approach for managing these patients should be highly encouraged.

Citations

Citations to this article as recorded by  
  • Inter‐relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management
    Jiten Vora, David Cherney, Mikhail N. Kosiborod, Jonas Spaak, Naresh Kanumilli, Kamlesh Khunti, Carolyn S. P. Lam, Michael Bachmann, Peter Fenici
    Diabetes, Obesity and Metabolism.2024; 26(5): 1567.     CrossRef
  • Non‐alcoholic fatty liver modifies associations of body mass index and waist circumference with cardiometabolic risk: The CARDIA study
    Mahesh Mathew, Zachary C. Pope, Pamela J. Schreiner, David R. Jacobs, Lisa B. VanWagner, James G. Terry, Mark A. Pereira
    Obesity Science & Practice.2024;[Epub]     CrossRef
  • Relationship between fibrosis-4 score and microvascular complications in patients with type 2 diabetes mellitus
    Beril Turan Erdogan, Abbas Ali Tam, Husniye Baser, Fatma Neslihan Cuhaci Seyrek, Sefika Burcak Polat, Reyhan Ersoy, Oya Topaloglu, Bekir Cakir
    Arab Journal of Gastroenterology.2024; 25(3): 269.     CrossRef
  • Acute Kidney Injury in Patients with Chronic Liver Disease: A Review
    Hilary A. Elom, Yassmin Hegazy, Edgar V Lerma, Mohamed Hassanein
    Indian Journal of Nephrology.2024; 0: 1.     CrossRef
  • Investigation of cardiovascular risk factors in diabetic and nondiabetic patients with nonalcoholic fatty liver disease
    Mona Barati, Azam Teimouri, Awat Feizi, Bijan Iraj, Mozhgan Karimifar
    Journal of Research in Medical Sciences.2024;[Epub]     CrossRef
  • Relationship between Uric Acid to High Density Lipoprotein Cholesterol Ratio and Nonalcoholic Fatty Liver Disease in Nonoverweight/Obese Patients with Type 2 Diabetes
    Yuliang Cui, Zhenzhen Qu, Wenmei Hu, Haiyan Shi, Faustino R. Perez-Lopez
    International Journal of Endocrinology.2023; 2023: 1.     CrossRef
  • Emerging Role of Protein O-GlcNAcylation in Liver Metabolism: Implications for Diabetes and NAFLD
    Ziyan Xie, Ting Xie, Jieying Liu, Qian Zhang, Xinhua Xiao
    International Journal of Molecular Sciences.2023; 24(3): 2142.     CrossRef
  • Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
    Eugene Han, Yong-ho Lee
    Clinical and Molecular Hepatology.2023; 29(4): 980.     CrossRef
  • Factores de riesgo para fibrosis hepática en pacientes diabéticos con enfermedad renal cronica terminal
    Ismael Yepes Barreto, Diana Romero Florez, Jorge Coronado Daza
    Revista colombiana de Gastroenterología.2023; 38(3): 278.     CrossRef
  • Circ_0004535/miR-1827/CASP8 network involved in type 2 diabetes mellitus with nonalcoholic fatty liver disease
    Min Li, Ai Zeng, Xinle Tang, Hui Xu, Wei Xiong, Yanying Guo
    Scientific Reports.2023;[Epub]     CrossRef
  • Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
    Cheng-Wei Yu, Chia-Hung Chen, Yung-Chi Cheng, Wen-Che Hsieh, Tzu-Ju Hsu, Fuu-Jen Tsai, Chao-Yu Hsu
    European Journal of Medical Research.2023;[Epub]     CrossRef
  • A GLP‐1/GLP‐2 receptor dual agonist to treat NASH: Targeting the gut‐liver axis and microbiome
    Eun Ran Kim, Jeong Su Park, Jin Hee Kim, Ji Young Oh, In Jeong Oh, Da Hyun Choi, Yu seol Lee, I. Seul Park, SeungWon Kim, Da Hyun Lee, Jae Hee Cheon, Jin‐Woo Bae, Minyoung Lee, Jin Won Cho, In Bok An, Eun Joo Nam, Sang‐In Yang, Myung‐Shik Lee, Soo Han Bae
    Hepatology.2022; 75(6): 1523.     CrossRef
  • Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
    Ji-Yeon Lee, Young-eun Kim, Kyungdo Han, Eugene Han, Byung Wan Lee, Eun Seok Kang, Bong-Soo Cha, Seung-Hyun Ko, Yong-ho Lee
    JAMA Network Open.2022; 5(2): e220262.     CrossRef
  • State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis
    Yongin Cho, Yong-ho Lee
    Endocrinology and Metabolism.2022; 37(1): 38.     CrossRef
  • Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
    Iresha Sandamali Koralegedara, Janith Niwanthaka Warnasekara, Ashani Rathnayake, Korale Gedara Dayaratne, Suneth Buddhika Agampodi
    BMJ Open Gastroenterology.2022; 9(1): e000913.     CrossRef
  • A Prediction Model of the Incidence of Nonalcoholic Fatty Liver Disease With Visceral Fatty Obesity: A General Population-Based Study
    Yang Zhou, Xiangping Chai, Tuo Guo, Yuting Pu, Mengping Zeng, Aifang Zhong, Guifang Yang, Jiajia Cai
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Non-alcoholic fatty liver disease and sarcopenia is associated with the risk of albuminuria independent of insulin resistance, and obesity
    Eugene Han, Mi Kyung Kim, Seung-Soon Im, Byoung Kuk Jang, Hye Soon Kim
    Journal of Diabetes and its Complications.2022; 36(8): 108253.     CrossRef
  • Increased Risk of NAFLD in Adults with Glomerular Hyperfiltration: An 8-Year Cohort Study Based on 147,162 Koreans
    Dae-Jeong Koo, Mi Yeon Lee, Inha Jung, Sun Joon Moon, Hyemi Kwon, Eun-Jung Rhee, Cheol-Young Park, Won-Young Lee, Ki Won Oh, Se Eun Park
    Journal of Personalized Medicine.2022; 12(7): 1142.     CrossRef
  • Effects of Avocado Oil Supplementation on Insulin Sensitivity, Cognition, and Inflammatory and Oxidative Stress Markers in Different Tissues of Diet-Induced Obese Mice
    Schérolin de Oliveira Marques, Alexandre Pastoris Muller, Thais Fernandes Luciano, Natália dos Santos Tramontin, Mateus da Silva Caetano, Bruno Luis da Silva Pieri, Tatiane Lima Amorim, Marcone Augusto Leal de Oliveira, Cláudio Teodoro de Souza
    Nutrients.2022; 14(14): 2906.     CrossRef
  • Relationship Between Handgrip Strength and Laboratory Values in Adolescents With Non-Alcoholic Fatty Liver Disease
    Si Yeong Lee, Yong Whi Jeong, Hong Koh, Yunkoo Kang
    Journal of Clinical Densitometry.2022; 25(4): 490.     CrossRef
  • Association between non-alcoholic fatty liver disease and metabolically healthy deterioration across different body shape phenotypes at baseline and change patterns
    Liu Lei, Wang Changfa, Wang Jiangang, Chen Zhiheng, Yuan Ting, Zhu Xiaoling, Deng Yuling, Wang Yaqin
    Scientific Reports.2022;[Epub]     CrossRef
  • Muscle fat contents rather than muscle mass determines nonalcoholic steatohepatitis and liver fibrosis in patients with severe obesity
    Eugene Han, Mi Kyung Kim, Hye Won Lee, Seungwan Ryu, Hye Soon Kim, Byoung Kuk Jang, Youngsung Suh
    Obesity.2022; 30(12): 2440.     CrossRef
  • Prediction of decreased estimated glomerular filtration rate using liver fibrosis markers: a renal biopsy-based study
    Akira Mima
    Scientific Reports.2022;[Epub]     CrossRef
  • Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease
    Mehmet Kanbay, Mustafa C. Bulbul, Sidar Copur, Baris Afsar, Alan A. Sag, Dimitrie Siriopol, Masanari Kuwabara, Silvia Badarau, Adrian Covic, Alberto Ortiz
    Journal of Nephrology.2021; 34(3): 649.     CrossRef
  • Taxifolin ameliorate high-fat-diet feeding plus acute ethanol binge-induced steatohepatitis through inhibiting inflammatory caspase-1-dependent pyroptosis
    Zi-Ying Zhan, Mei Wu, Yue Shang, Min Jiang, Jian Liu, Chun-Ying Qiao, Huan Ye, Yong-Ce Lin, Mei-Hua Piao, Rong-Hui Sun, Zhi-Hong Zhang, Jing-Ya Jiao, Yan-Ling Wu, Ji-Xing Nan, Li-Hua Lian
    Food & Function.2021; 12(1): 362.     CrossRef
  • Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
    Eugene Han, Mi Kyung Kim, Byoung Kuk Jang, Hye Soon Kim
    Diabetes & Metabolism Journal.2021; 45(5): 698.     CrossRef
  • The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008–2011)
    Hyun Min Kim, Yong-ho Lee
    Endocrinology and Metabolism.2021; 36(6): 1232.     CrossRef
  • A preliminary report about the detection of ventricular repolarisation in patients with non-alcoholic fatty liver disease
    Marwan S. Al-Nimer, Vian A. Esmail, Dler S. Hamid, Mohammad O. Mohammad
    Journal of Taibah University Medical Sciences.2020; 15(4): 284.     CrossRef
  • Atorvastatin attenuates obese-induced kidney injury and impaired renal organic anion transporter 3 function through inhibition of oxidative stress and inflammation
    Nattavadee Pengrattanachot, Rada Cherngwelling, Krit Jaikumkao, Anchalee Pongchaidecha, Laongdao Thongnak, Myat Theingi Swe, Varanuj Chatsudthipong, Anusorn Lungkaphin
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2020; 1866(6): 165741.     CrossRef
  • Correlation Between Non-Alcoholic Fatty Liver and Chronic Kidney Disease
    Hasyim Kasim, St. Rabiul Zatalia, Haerani Rasyid, Syakib Bakri, Muhammad L. Parewangi, Fardah Akil, Arifin Seweng
    The Open Urology & Nephrology Journal.2020; 13(1): 1.     CrossRef
  • Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
    Byung-Wan Lee, Yong-ho Lee, Cheol-Young Park, Eun-Jung Rhee, Won-Young Lee, Nan-Hee Kim, Kyung Mook Choi, Keun-Gyu Park, Yeon-Kyung Choi, Bong-Soo Cha, Dae Ho Lee
    Diabetes & Metabolism Journal.2020; 44(3): 382.     CrossRef
  • Sarcopenia: an emerging risk factor for non-alcoholic fatty liver disease
    Yong-ho Lee, Seung Up Kim
    Hepatology International.2020; 14(1): 5.     CrossRef
  • Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus
    Hokyou Lee, Gyuri Kim, Young Ju Choi, Byung Wook Huh, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Eun Jig Lee, Yong-ho Lee, Kap Bum Huh
    Diabetes & Metabolism Journal.2020; 44(2): 267.     CrossRef
  • Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial
    Eugene Han, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
    Journal of Clinical Medicine.2020; 9(1): 259.     CrossRef
  • Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
    Hyeok-Hee Lee, Yongin Cho, Young Ju Choi, Byung Wook Huh, Byung-Wan Lee, Eun Seok Kang, Seok Won Park, Bong-Soo Cha, Eun Jig Lee, Yong-ho Lee, Kap Bum Huh
    Cardiovascular Diabetology.2020;[Epub]     CrossRef
  • Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes
    Eugene Han, Yongin Cho, Kyung-won Kim, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-wan Lee
    Medicine.2020; 99(33): e21038.     CrossRef
  • Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west?
    Min Zhang, Su Lin, Ming-fang Wang, Jiao-feng Huang, Shi-ying Liu, Su-mei Wu, Hao-yang Zhang, Zi-mu Wu, Wen-Yue Liu, Dong-Chu Zhang, Chuan-ming Hao, Yue-yong Zhu, Ming-Hua Zheng, Xiao-zhong Wang
    BMC Gastroenterology.2020;[Epub]     CrossRef
  • Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes
    Inkuk Lee, Hyeok-Hee Lee, Yongin Cho, Young Ju Choi, Byung Wook Huh, Byung-Wan Lee, Eun Seok Kang, Seok Won Park, Bong-Soo Cha, Eun Jig Lee, Yong-ho Lee, Kap Bum Huh
    Journal of Lipid and Atherosclerosis.2020; 9(1): 195.     CrossRef
  • Letter: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38)
    Chan-Hee Jung
    Journal of Obesity & Metabolic Syndrome.2020; 29(2): 158.     CrossRef
  • Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An Overview
    Niki Katsiki, Anca Pantea Stoian, Paschalis Steiropoulos, Nikolaos Papanas, Andra-Iulia Suceveanu, Dimitri P. Mikhailidis
    Metabolites.2020; 10(11): 465.     CrossRef
  • Heart Failure and Liver Disease
    Andrew Xanthopoulos, Randall C. Starling, Takeshi Kitai, Filippos Triposkiadis
    JACC: Heart Failure.2019; 7(2): 87.     CrossRef
  • Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients
    Asieh Mansour, Mohammad Reza Mohajeri-Tehrani, Majid Samadi, Hadis Gerami, Mostafa Qorbani, Nick Bellissimo, Hossein Poustchi, Azita Hekmatdoost
    Acta Diabetologica.2019; 56(11): 1199.     CrossRef
  • Targeting CYP4A attenuates hepatic steatosis in a novel multicellular organotypic liver model
    Jae-Sung Ryu, Minji Lee, Seon Ju Mun, Sin-Hyoung Hong, Ho-Joon Lee, Hyo-Suk Ahn, Kyung-Sook Chung, Gun-Hwa Kim, Myung Jin Son
    Journal of Biological Engineering.2019;[Epub]     CrossRef
  • Non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatment
    Niki Katsiki, Vasilios G Athyros
    Current Medical Research and Opinion.2019; 35(7): 1305.     CrossRef
  • Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
    Yong-ho Lee, Yongin Cho, Byung-Wan Lee, Cheol-Young Park, Dae Ho Lee, Bong-Soo Cha, Eun-Jung Rhee
    Diabetes & Metabolism Journal.2019; 43(1): 31.     CrossRef
  • Progress in the Study of the Pathogenesis of Chronic Kidney Disease Associated with Nonalcoholic Fatty Liver Disease
    清莲 宋
    Advances in Clinical Medicine.2019; 09(09): 1073.     CrossRef
  • Association Between Nonalcoholic Fatty Liver Disease and Future Deterioration of Metabolic Health: A Cohort Study
    You‐Cheol Hwang, Hong‐Yup Ahn, Cheol‐Young Park
    Obesity.2019; 27(8): 1360.     CrossRef
  • Subfornical organ insulin receptors tonically modulate cardiovascular and metabolic function
    Jin Kwon Jeong, Julie A. Horwath, Hayk Simonyan, Katherine A. Blackmore, Scott D. Butler, Colin N. Young
    Physiological Genomics.2019; 51(8): 333.     CrossRef
  • Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
    Kyung-Soo Kim, Byung-Wan Lee, Yong Jin Kim, Dae Ho Lee, Bong-Soo Cha, Cheol-Young Park
    Diabetes & Metabolism Journal.2019; 43(2): 127.     CrossRef
  • Chicken Protein Hydrolysates Have Anti-Inflammatory Effects on High-Fat Diet Induced Obesity in Mice
    Thomas A. Aloysius, Ana Karina Carvajal, Rasa Slizyte, Jon Skorve, Rolf K. Berge, Bodil Bjørndal
    Medicines.2018; 6(1): 5.     CrossRef
  • STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia
    Emmelie Cansby, Elin Magnusson, Esther Nuñez-Durán, Manoj Amrutkar, Matteo Pedrelli, Paolo Parini, Jenny Hoffmann, Marcus Ståhlman, Brian W. Howell, Hanns-Ulrich Marschall, Jan Borén, Margit Mahlapuu
    Arteriosclerosis, Thrombosis, and Vascular Biology.2018; 38(8): 1723.     CrossRef
  • Organ-Specific Mechanisms of Transendothelial Neutrophil Migration in the Lung, Liver, Kidney, and Aorta
    Sanne L. Maas, Oliver Soehnlein, Joana R. Viola
    Frontiers in Immunology.2018;[Epub]     CrossRef
  • Visceral adiposity index as a predictor of NAFLD: A prospective study with 4‐year follow‐up
    Chaonan Xu, Zhimin Ma, Yunfeng Wang, Xiangtong Liu, Lixin Tao, Deqiang Zheng, Xiuhua Guo, Xinghua Yang
    Liver International.2018; 38(12): 2294.     CrossRef
  • Obesity induced alterations in redox homeostasis and oxidative stress are present from an early age
    Alfonso M. Lechuga-Sancho, David Gallego-Andujar, Pablo Ruiz-Ocaña, Francisco M. Visiedo, Ana Saez-Benito, Mónica Schwarz, Carmen Segundo, Rosa M. Mateos, Manuel Portero-Otin
    PLOS ONE.2018; 13(1): e0191547.     CrossRef
  • Capybara Oil Improves Hepatic Mitochondrial Dysfunction, Steatosis, and Inflammation in a Murine Model of Nonalcoholic Fatty Liver Disease
    Polyana C. Marinho, Aline B. Vieira, Priscila G. Pereira, Kíssila Rabelo, Bianca T. Ciambarella, Ana L. R. Nascimento, Erika Cortez, Aníbal S. Moura, Fernanda V. Guimarães, Marco A. Martins, Gonzalo Barquero, Rodrigo N. Ferreira, Jorge J. de Carvalho, Yua
    Evidence-Based Complementary and Alternative Medicine.2018;[Epub]     CrossRef
  • Persistently Increased Resting Energy Expenditure Predicts Short-Term Mortality in Patients with Acute-on-Chronic Liver Failure
    Jia Yao, Xiaoshuang Zhou, Hui Wang, Lili Yuan, Yu Chen, Zhongping Duan
    Annals of Nutrition and Metabolism.2018; 73(1): 2.     CrossRef
  • The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice
    Dong Wang, Yuhuan Luo, Xiaoxin Wang, David Orlicky, Komuraiah Myakala, Pengyuan Yang, Moshe Levi
    International Journal of Molecular Sciences.2018; 19(1): 137.     CrossRef
  • Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults
    Jing Luo, Qian Chen, Tianran Shen, Xu Wang, Wanjun Fang, Xiaocai Wu, Zenan Yuan, Gengdong Chen, Wenhua Ling, Yuming Chen
    Nutrition & Metabolism.2018;[Epub]     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP